NCT06908096
- Conditions
- DNA Virus Infections, EBV, Epstein-Barr Virus Infection, +14 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,016 public trials
2,026 recruiting studies
Lymphoproliferative Disorders trial results
NCT00006518
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +35 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
NCT07570173
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Rigshospitalet ( Site 0802) Copenhagen, Capital Region, Denmark
- Aarhus Universitetshospital. Hæmatologisk afdeling ( Site 0804) Aarhus Nord, Central Jutland, Denmark
- Odense Universitetshospital ( Site 0801) Odense, Region Syddanmark, Denmark
- Rambam Health Care Campus ( Site 0903) Haifa, Israel
NCT06311227
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope at Irvine Lennar Irvine, California, United States
- UM Sylvester Comprehensive Cancer Center at Aventura Aventura, Florida, United States
- UM Sylvester Comprehensive Cancer Center at Coral Gables Coral Gables, Florida, United States
NCT07519772
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Colorado Blood Cancer Institute ( Site 7000) Denver, Colorado, United States
- SCRI Oncology Partners ( Site 0100) Nashville, Tennessee, United States
- Instituto Alexander Fleming ( Site 1404) Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Sanatorio Nuestra Senora del Rosario ( Site 1403) Rosario, Santa Fe Province, Argentina
NCT03739814
- Conditions
- B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Burkitt Lymphoma, DNA Virus Infections, +17 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
NCT04045470
- Conditions
- Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
NCT07634471
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- SCRI Oncology Partners ( Site 7000) Nashville, Tennessee, United States
- Hadassah Medical Center ( Site 0701) Jerusalem, Israel
- Sheba Medical Center ( Site 0702) Ramat Gan, Israel
- Sourasky Medical Center ( Site 0704) Tel Aviv, Israel
NCT06395103
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
- Locations
-
- Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
- Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
- Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
Recruiting
The CARDIOPROTECT Trial
NCT07654426
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +18 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States